GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (ASX:IPD) » Definitions » Gross Profit

Impedimed (ASX:IPD) Gross Profit : A$8.74 Mil (TTM As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Impedimed Gross Profit?

Impedimed's gross profit for the six months ended in Jun. 2024 was A$4.67 Mil. Impedimed's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was A$8.74 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Impedimed's gross profit for the six months ended in Jun. 2024 was A$4.67 Mil. Impedimed's Revenue for the six months ended in Jun. 2024 was A$5.35 Mil. Therefore, Impedimed's Gross Margin % for the quarter that ended in Jun. 2024 was 87.25%.

Impedimed had a gross margin of 87.25% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Impedimed was 86.93%. The lowest was 66.73%. And the median was 73.78%.


Impedimed Gross Profit Historical Data

The historical data trend for Impedimed's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Gross Profit Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.02 6.75 8.79 9.70 8.74

Impedimed Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.41 4.80 4.91 4.07 4.67

Competitive Comparison of Impedimed's Gross Profit

For the Medical Devices subindustry, Impedimed's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Impedimed's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Gross Profit distribution charts can be found below:

* The bar in red indicates where Impedimed's Gross Profit falls into.



Impedimed Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Impedimed's Gross Profit for the fiscal year that ended in Jun. 2024 is calculated as

Gross Profit (A: Jun. 2024 )=Revenue - Cost of Goods Sold
=10.053 - 1.314
=8.74

Impedimed's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=5.351 - 0.682
=4.67

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$8.74 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Impedimed's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=4.67 / 5.351
=87.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Impedimed  (ASX:IPD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Impedimed had a gross margin of 87.25% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Impedimed Gross Profit Related Terms

Thank you for viewing the detailed overview of Impedimed's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

No Headlines